Muscarinic mechanisms of antipsychotic atypicality

被引:111
作者
Bymaster, FP [1 ]
Felder, CC [1 ]
Tzavara, E [1 ]
Nomikos, GG [1 ]
Calligaro, DO [1 ]
Mckinzie, DL [1 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Neurosci Res Div, Indianapolis, IN 46285 USA
关键词
atypical antipsychotics; clozapine; muscarinic; olanzapine; quetiapine; risperidone; schizophrenia; ziprasidone;
D O I
10.1016/j.pnpbp.2003.09.008
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The interactions of the atypical antipsychotic drugs (APD) clozapine, olanzapine, risperidone, quetiapine and ziprasidone with muscarinic receptors were reviewed. Only clozapine and olanzapine have marked affinity for muscarinic receptors in radioligand binding studies; however, the affinity of these compounds is considerably lower than classical muscarinic antagonists. Although functional assays in cell lines transfected with muscarinic receptors suggest that olanzapine and clozapine have weak partial agonist activity at muscarinic receptors, particularly M-4 receptors, studies in vitro and in vivo indicate that the compounds function as antagonists. In animal studies and in humans, clozapine has pronounced antimuscarinic effects whereas olanzapine has weak antimuscarinic effects. However, olanzapine significantly occupies central muscarinic receptors in humans. Overall, the role of muscarinic receptors in the antipsychotic effects of clozapine and olanzapine is controversial and complex. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:1125 / 1143
页数:19
相关论文
共 120 条
[1]   Scopolamine does not restore normal conditioned avoidance performance in raclopride-treated rats [J].
Ahlenius, S ;
Ericson, E .
JOURNAL OF NEURAL TRANSMISSION, 2001, 108 (04) :415-430
[2]   Clozapine withdrawal emergent dystonias and dyskinesias: A case series [J].
Ahmed, S ;
Chengappa, KNR ;
Naidu, VR ;
Baker, RW ;
Parepally, H ;
Schooler, NR .
JOURNAL OF CLINICAL PSYCHIATRY, 1998, 59 (09) :472-477
[3]   Neuroleptic sensitivity and enzyme deficiency in two schizophrenic brothers: A case report [J].
Aitchison, KJ ;
Patel, M ;
Taylor, M ;
Murray, RM ;
Arranz, MJ ;
Collier, DA ;
Kerwin, RW .
SCHIZOPHRENIA RESEARCH, 1996, 18 (2-3) :152-152
[4]   Atropine acts in the ventral striatum to reduce raclopride-induced catalepsy [J].
Alcock, SJ ;
Hemsley, KM ;
Crocker, AD .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 424 (03) :179-187
[5]   MODULATORY EFFECT OF CLOZAPINE ON LEVODOPA RESPONSE IN PARKINSONS-DISEASE - A PRELIMINARY-STUDY [J].
AREVALO, GJG ;
GERSHANIK, OS .
MOVEMENT DISORDERS, 1993, 8 (03) :349-354
[6]   Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence [J].
Arnt, J ;
Skarsfeldt, T .
NEUROPSYCHOPHARMACOLOGY, 1998, 18 (02) :63-101
[7]  
ARNT J, 1981, NEUROPHARMACOLOGY, V20, P1331
[8]  
BALDWIN DS, 1995, INT CLIN PSYCHOPHARM, V122, P198
[9]   Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia [J].
Basile, AS ;
Fedorova, I ;
Zapata, A ;
Liu, XG ;
Shippenberg, T ;
Duttaroy, A ;
Yamada, M ;
Wess, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) :11452-11457
[10]   Olanzapine versus placebo: Results of a double-blind, fixed-dose olanzapine trial [J].
Beasley, CM ;
Sanger, T ;
Satterlee, W ;
Tollefson, G ;
Tran, P ;
Hamilton, S ;
Green, A ;
Dott, S ;
Pfister, G ;
Roxas, L ;
Small, J ;
Thomas, M ;
Ames, D ;
Schooler, N ;
Baker, R ;
Levine, R ;
Fabre, L ;
Friedel, R ;
Safferman, A ;
Lieberman, J ;
Stahl, S .
PSYCHOPHARMACOLOGY, 1996, 124 (1-2) :159-167